Search
Login
My Portfolios Login
TradeMachine® Login
TradeMachine®Stock Login
NEW
CML Research Pro Login
Get TradeMachine
Get TradeMachine®
Get TradeMachine® Stock
NEW
Get CML Research
Compare Products
Home
My Portfolios
CMLViz News
Breaking
Stocks
Tear Sheet
News
Profile
Stats
Stock Chart
Pivot Points
Financial Charts
Insiders
Analysts
Day Trader
Back-Tester
SPX
4,168.60
+36.27
(
+0.87%
)
Dow 30
+0.55%
Nasdaq 100
+0.87%
VIX
17.25
-1.46
(
-7.80%
)
Abbvie Inc
NYSE:ABBV 11:12:30 AM EDT
111.54
+1.49
(
+1.35%
)
Products
AbbVie Submits Regulatory Applications For SKYRIZI In Psoriatic Arthritis To FDA And EMA
Published: 04/07/2021 13:12 GMT
ABBV
Abbvie Inc (
ABBV
)
- Abbvie Submits Regulatory Applications for Skyrizi® (risankizumab) in Psoriatic Arthritis to FDA and Ema.